Nakanishi Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Nakanishi Inc.'s yearly results (2022–2025), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 67% in 3 years, but profit fell: ¥46 less profit per ¥100 of extra sales. Lower than 92% of Healthcare companies in Japan.
Where ¥100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥140Over the last 3 years, every ¥100 of reported profit came with ¥140 of operating cash.
Higher than 57% of Healthcare companies in Japan.
Self-Funding Ratio
2.5×Over the last 3 years its own operating cash covered its investment spending (capex) 2.5 times.
Higher than 68% of Healthcare companies in Japan.
Cash Locked Ratio
¥36For every ¥100 of sales, ¥36 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥38 tied up three years earlier.
More money tied up than 72% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Less steady than 55% of Healthcare companies in Japan.
Growth Efficiency Ratio
−¥46Sales grew 67% in 3 years, but profit fell: ¥46 less profit per ¥100 of extra sales.
Lower than 92% of Healthcare companies in Japan.
Asset Productivity Ratio
+67% / +56%In 3 years sales changed by +67% while total assets changed by +56%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
1.1×Debt due within a year is covered 1.1 times by its yearly operating cash.
Higher than 55% of Healthcare companies in Japan.
Cash Cushion Ratio
+15%Cash, after subtracting all debt, equals 15% of its market value (net cash).
Higher than 70% of Healthcare companies in Japan.
Tangible Assets Ratio
87%Of every ¥100 the company owns, ¥87 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 75% of Healthcare companies in Japan.
Tangible Net Worth Ratio
81%Of every ¥100 of net worth, ¥81 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 71% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Nakanishi Inc. owes ¥0.30 for every ¥1 it owns. Nakanishi Inc. made a loss in the year to Dec 2025, after a profit the year before.
Compared with Healthcare companies in Japan · latest annual results Dec 2025.
P/E ratio
105.3Investors pay ¥105.3 for every ¥1 of Nakanishi Inc.'s yearly profit, higher than 97% of Healthcare companies in Japan.
P/B ratio
1.90The share price is 1.90 times Nakanishi Inc.'s book value per share, higher than 61% of Healthcare companies in Japan.
Market cap
¥232.3 BThe total market value of all of Nakanishi Inc.'s shares at today's price (share price × number of shares), larger than 85% of Healthcare companies in Japan. PosiCap size class: Meso Cap.
Net worth (book value)
¥122.0 BWhat Nakanishi Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥745.71Net worth divided by the number of shares. The share price of ¥1,420 is 1.9 times this, which is the P/B above.
Return on equity (ROE)
1.9%Nakanishi Inc. earned 1.9% on its shareholders' money over the last year, lower than 70% of Healthcare companies in Japan.
Owes vs Owns
0.30×Nakanishi Inc. owes ¥0.30 for every ¥1 it owns (low), lower than 58% of Healthcare companies in Japan.
Dividend yield
2.10%Nakanishi Inc. pays 2.10% of its share price as dividends a year, lower than 67% of dividend-paying Healthcare companies in Japan.
Revenue growth
+5%Revenue rose 5% in the year to Dec 2025, and grew 19% a year on average over 3 years.
Profit growth
LossNakanishi Inc. made a loss in the year to Dec 2025, after a profit the year before.
Profit margin
-3.0%Nakanishi Inc. lost ¥3 for every ¥100 of revenue.
Interest cover
70.7×Nakanishi Inc.'s operating profit covered its interest costs 70.7 times in the year to Dec 2025.
Cash vs debt
Net cashNakanishi Inc. held ¥36.0 B more cash than debt (net cash) at Dec 2025.
Questions
What is Nakanishi Inc.'s P/E ratio?
Investors pay ¥105.3 for every ¥1 of Nakanishi Inc.'s yearly profit, higher than 97% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Nakanishi Inc.: ¥232.3 B ÷ ¥122.0 B (30 Jun 2026) = 1.9.
What is Nakanishi Inc.'s return on equity?
Nakanishi Inc. earned 1.9% on its shareholders' money over the last year, lower than 70% of Healthcare companies in Japan.
How much does Nakanishi Inc. owe compared with what it owns?
Nakanishi Inc. owes ¥0.30 for every ¥1 it owns (low), lower than 58% of Healthcare companies in Japan.
Does Nakanishi Inc. pay a dividend?
Yes. Nakanishi Inc. pays 2.10% of its share price as dividends a year, lower than 67% of dividend-paying Healthcare companies in Japan.
Is Nakanishi Inc.'s revenue growing?
Revenue rose 5% in the year to Dec 2025, and grew 19% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.